• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Updating the basket of health services].

作者信息

Israeli Abraham, Chinitz David P

出版信息

Harefuah. 2003 Feb;142(2):100-2, 159.

PMID:12653041
Abstract

The process by which services are added to Israel's basic basket of health services constitutes a unique effort to tackle the most difficult of ethical issues. In some years, since 1997, the Israeli government allocated an increment of about 1% to the national health budget for the purpose of expanding the basic basket of health services provided under national health insurance. A public committee has been created for this purpose of deciding which of hundreds of potential entrants, should be added within the above budget constraint. The committee integrates available scientific evidence on effectiveness with social values to come up with a ranking. The process has attracted a great deal of public attention, most notably in the printed media, which usually focuses on the plight of specific individuals whose "desired drug" has not been added to the basket. In addition, the courts have, on occasion, intervened to reverse decisions of the committee in the contexts of suits brought by individuals seeking coverage for a treatment not currently included in the basket. Thus, Israel's brave attempt to cope with the necessity of health care rationing needs to be fine-tuned in terms of the information provided to the public about the process and the balance of scientific, economic, judicial and political inputs into the process.

摘要

相似文献

1
[Updating the basket of health services].
Harefuah. 2003 Feb;142(2):100-2, 159.
2
Regulating life and death: the case of Israel's "Health Basket" Committee.生死调控:以以色列“医疗服务包”委员会为例
J Contemp Health Law Policy. 2006 Fall;23(1):9-63.
3
Risk avoidance and missed opportunities in mental health reform: the case of Israel.心理健康改革中的风险规避与错失的机遇:以以色列为例
Int J Law Psychiatry. 2007 May-Jun;30(3):163-81. doi: 10.1016/j.ijlp.2007.03.001. Epub 2007 Apr 27.
4
Values, institutions and shifting policy paradigms: expansion of the Israeli National Health Insurance Basket of Services.价值观、制度与不断变化的政策范式:以色列国家医疗保险服务篮子的扩展
Health Policy. 2009 Apr;90(1):37-44. doi: 10.1016/j.healthpol.2008.08.010. Epub 2008 Oct 18.
5
Israel--a health system in transition.以色列——一个处于转型期的卫生系统。
Physician Exec. 1998 Mar-Apr;24(2):39-42.
6
Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.“婴儿多伊”事件重演?美国卫生与公众服务部及2002年《出生时存活婴儿保护法》:关于规范新生儿医疗行为的警示
Pediatrics. 2005 Oct;116(4):e576-85. doi: 10.1542/peds.2005-1590.
7
Estimating the budget impact of new technologies added to the National List of Health Services in Israel: stakeholders' incentives for adopting a financial risk-sharing mechanism.估算新增至以色列国家医疗服务清单的新技术的预算影响:利益相关者采用财务风险分担机制的激励因素。
Health Policy. 2009 Jan;89(1):78-83. doi: 10.1016/j.healthpol.2008.05.006. Epub 2008 Jun 24.
8
Family pediatrics: report of the Task Force on the Family.家庭儿科学:家庭问题特别工作组报告
Pediatrics. 2003 Jun;111(6 Pt 2):1541-71.
9
[Healthcare for migrant workers in Israel].[以色列农民工的医疗保健]
Harefuah. 2003 Jun;142(6):429-32, 486, 485.
10
Punctuated equilibrium and path dependency in coexistence: the Israeli health system and theories of change.共存中的间断平衡与路径依赖:以色列的医疗体系与变革理论。
J Health Polit Policy Law. 2010 Aug;35(4):595-614. doi: 10.1215/03616878-2010-018.

引用本文的文献

1
The National Immunization Technical Advisory Group in Israel.以色列国家免疫技术咨询小组。
Isr J Health Policy Res. 2021 Jan 26;10(1):7. doi: 10.1186/s13584-021-00442-4.
2
Do the equity-efficiency preferences of the Israeli Basket Committee match those of Israeli health policy makers?以色列篮筐委员会的公平-效率偏好与以色列卫生政策制定者的偏好相符吗?
Isr J Health Policy Res. 2017 Apr 30;6:20. doi: 10.1186/s13584-017-0145-4. eCollection 2017.
3
The shaping of pharmaceutical governance: the Israeli case.医药治理的塑造:以色列案例。
Isr J Health Policy Res. 2014 May 27;3:16. doi: 10.1186/2045-4015-3-16. eCollection 2014.
4
Which health technologies should be funded? A prioritization framework based explicitly on value for money.哪些卫生技术应该得到资助?一个明确基于性价比的优先排序框架。
Isr J Health Policy Res. 2012 Nov 26;1(1):44. doi: 10.1186/2045-4015-1-44.